Long Term Debt Summary of Kane Biotech Inc.

Kane Biotech Inc.'s latest annual long term debt in 2023 was 1.3 Million CAD , down -49.49% from previous year.
Kane Biotech Inc.'s latest quarterly long term debt in 2024 Q2 was 1.95 Million CAD , down -6.92% from previous quarter.
Kane Biotech Inc. reported annual long term debt of 2.57 Million CAD in 2022, up 17.04% from previous year.
Kane Biotech Inc. reported annual long term debt of 2.2 Million CAD in 2021, up 219.24% from previous year.
Kane Biotech Inc. reported quarterly long term debt of 1.95 Million CAD for 2024 Q2, down -6.92% from previous quarter.
Kane Biotech Inc. reported quarterly long term debt of 2.17 Million CAD for 2023 Q4, down -5.0% from previous quarter.

Annual Long Term Debt Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Long Term Debt of Kane Biotech Inc. (2023 - 2003)

Year	Long Term Debt	Long Term Debt Growth
2023	1.3 Million CAD	-49.49%
2022	2.57 Million CAD	17.04%
2021	2.2 Million CAD	219.24%
2020	690.17 Thousand CAD	321.81%
2019	163.62 Thousand CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	-100.0%
2016	29.97 Thousand CAD	-93.17%
2015	438.64 Thousand CAD	0.0%
2014	- CAD	-100.0%
2013	413.24 Thousand CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%
2005	- CAD	0.0%
2004	- CAD	0.0%
2003	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.22 Million CAD	-6.27%
2024 Q2	1.95 Million CAD	-6.92%
2023 Q4	2.17 Million CAD	-5.0%
2023 Q3	2.28 Million CAD	55.57%
2023 Q1	2.5 Million CAD	-2.73%
2023 FY	1.3 Million CAD	-49.49%
2023 Q2	1.47 Million CAD	-41.33%
2022 Q2	2.51 Million CAD	-0.38%
2022 FY	2.57 Million CAD	17.04%
2022 Q1	2.52 Million CAD	14.42%
2022 Q3	2.4 Million CAD	-4.38%
2022 Q4	2.57 Million CAD	7.39%
2021 FY	2.2 Million CAD	219.24%
2021 Q2	1.84 Million CAD	156.05%
2021 Q3	1.91 Million CAD	3.74%
2021 Q4	2.2 Million CAD	14.84%
2021 Q1	722.27 Thousand CAD	4.65%
2020 FY	690.17 Thousand CAD	321.81%
2020 Q1	301.25 Thousand CAD	84.12%
2020 Q2	491.63 Thousand CAD	63.2%
2020 Q3	699.26 Thousand CAD	42.23%
2020 Q4	690.17 Thousand CAD	-1.3%
2019 Q1	- CAD	0.0%
2019 FY	163.62 Thousand CAD	0.0%
2019 Q3	145.24 Thousand CAD	0.0%
2019 Q2	- CAD	0.0%
2019 Q4	163.62 Thousand CAD	12.65%
2018 Q3	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q1	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 FY	- CAD	-100.0%
2017 Q3	- CAD	0.0%
2016 Q2	457.78 Thousand CAD	-1.14%
2016 FY	29.97 Thousand CAD	-93.17%
2016 Q1	463.04 Thousand CAD	5.56%
2016 Q4	- CAD	-100.0%
2016 Q3	468.4 Thousand CAD	2.32%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q4	438.64 Thousand CAD	0.0%
2015 FY	438.64 Thousand CAD	0.0%
2014 Q3	434.62 Thousand CAD	3.02%
2014 Q4	- CAD	-100.0%
2014 Q1	410.12 Thousand CAD	-0.76%
2014 FY	- CAD	-100.0%
2014 Q2	421.87 Thousand CAD	2.87%
2013 Q1	- CAD	0.0%
2013 FY	413.24 Thousand CAD	0.0%
2013 Q4	413.24 Thousand CAD	0.0%
2013 Q3	- CAD	0.0%
2013 Q2	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 Q3	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q3	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q1	- CAD	0.0%
2009 Q1	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q2	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 Q1	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q1	- CAD	0.0%
2007 Q2	- CAD	0.0%
2007 Q3	- CAD	0.0%
2007 Q4	- CAD	0.0%
2006 Q2	- CAD	0.0%
2006 Q1	- CAD	0.0%
2006 FY	- CAD	0.0%
2006 Q4	- CAD	0.0%
2006 Q3	- CAD	0.0%
2005 Q4	- CAD	0.0%
2005 Q1	- CAD	0.0%
2005 Q2	- CAD	0.0%
2005 FY	- CAD	0.0%
2005 Q3	- CAD	0.0%
2004 Q1	- CAD	0.0%
2004 Q4	- CAD	0.0%
2004 Q3	- CAD	0.0%
2004 Q2	- CAD	0.0%
2004 FY	- CAD	0.0%
2003 FY	- CAD	0.0%
2003 Q4	- CAD	0.0%
2003 Q2	- CAD	0.0%
2003 Q3	- CAD	0.0%

Peer Long Term Debt Comparison of Kane Biotech Inc.

Name	Long Term Debt	Long Term Debt Difference
ContraFect Corporation	2.21 Million USD	41.065%
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	93.771%
Intellipharmaceutics International Inc.	- USD	-Infinity%
Evofem Biosciences, Inc.	8000.00 USD	-16180.788%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	25.806%
Propanc Biopharma, Inc.	58.64 Thousand USD	-2121.041%
Marizyme, Inc.	667.12 Thousand USD	-95.234%
Genus plc	228.2 Million USD	99.429%
Pharming Group N.V.	166.1 Million USD	99.216%
Therapeutic Solutions International, Inc.	5512.00 USD	-23529.59%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	7.161%
IMV Inc.	27.39 Million USD	95.246%
AXIM Biotechnologies, Inc.	5.42 Million USD	75.998%
ONE Bio Corp.	592.19 Thousand USD	-119.937%
RVL Pharmaceuticals plc	55.61 Million USD	97.658%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	-6.033%
Biomind Labs Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	-134.852%
Oncotelic Therapeutics, Inc.	1.89 Million USD	31.394%
Skye Bioscience, Inc.	171.23 Thousand USD	-660.651%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
Mesoblast Limited	100.29 Million USD	98.701%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	-304.492%
MultiCell Technologies, Inc.	36.43 USD	-3575148.422%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	11.23 Billion USD	99.988%
Arno Therapeutics, Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Halberd Corporation	150 Thousand USD	-768.309%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Nuo Therapeutics, Inc.	164.2 Thousand USD	-693.193%
argenx SE	15.35 Million USD	91.517%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	41.489%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
Bioxytran, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-29129.421%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	-931.229%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	-468.039%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Genscript Biotech Corporation	287.12 Million USD	99.546%
Kadimastem Ltd	229.69 Thousand USD	-467.05%
Helix BioMedix, Inc.	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-5048.279%
Capstone Therapeutics Corp.	8.26 Million USD	84.239%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
EV Biologics, Inc.	- USD	-Infinity%
Reve Technologies, Inc.	1064.00 USD	-122311.936%
Q BioMed Inc.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-770.549%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	20.31 Million USD	93.588%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Ember Therapeutics, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	265.63 Thousand USD	-390.321%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Qrons Inc.	80 Thousand USD	-1528.079%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	83.344%
SYBLEU INC	300 Thousand USD	-334.154%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-770.549%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	-252.924%
Affymax, Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
International Stem Cell Corporation	445 Thousand USD	-192.688%
CytoDyn Inc.	141 Thousand USD	-823.733%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	84.019%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	-185.003%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	-12.185%
PureTech Health plc	18.25 Million USD	92.863%
Coeptis Therapeutics, Inc.	150 Thousand USD	-768.309%
IXICO plc	275 Thousand USD	-373.623%
IntelGenx Technologies Corp.	11.83 Million USD	88.999%
Gelesis Holdings, Inc.	26.3 Million USD	95.049%
CSL Limited	11.23 Billion USD	99.988%
Cellectis S.A.	36.21 Million USD	96.403%

Global Stocks Search

Kane Biotech Inc. (KNBIF)

Long Term Debt Summary of Kane Biotech Inc.

Annual Long Term Debt Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Long Term Debt of Kane Biotech Inc. (2023 - 2003)

Peer Long Term Debt Comparison of Kane Biotech Inc.